Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo ClinicSeptember 29th, 2021|Cell and Gene Therapy, Innovation, Regional News Roundup|0 Comments Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.Article from PR NewswireShare This Story, Choose Your PlatformFacebookTwitterLinkedInPinterestEmail Related Posts Penn Announces Strategic Partnership with Longfellow Real Estate to Develop State-of-the-Art Life Sciences Facility in Philadelphia Stories From Our Region – May 2022 Stories From Our Region – April 2022 Regional Leaders Praise Greater Philadelphia’s Culture, Cuisine, and Quality of Life Stories From Our Region – March 2022 Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Current ye@r * Leave this field empty
Leave A Comment